Cargando…
Assessing thrombogenesis and treatment response in congenital thrombotic thrombocytopenic purpura
Despite clinical remission and normal platelet counts, congenital TTP (cTTP) is associated with non‐overt symptoms. Prophylactic ADAMTS13 replacement therapy such as plasma infusion (PI) prevents acute episodes and improves symptomatology. There is no current method to investigate disease severity o...
Autores principales: | Alwan, Ferras, Vendramin, Chiara, Budde, Ulrich, Liesner, Ri, Taylor, Alice, Thomas, Mari, Lämmle, Bernhard, Scully, Marie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175835/ https://www.ncbi.nlm.nih.gov/pubmed/35845267 http://dx.doi.org/10.1002/jha2.178 |
Ejemplares similares
-
Unmet needs in the management of immune‐mediated thrombotic thrombocytopenic purpura and the potential role of caplacizumab in the UK—A modified‐Delphi study
por: Scully, Marie, et al.
Publicado: (2022) -
Plasma exchange for COVID‐19 thrombo‐inflammatory disease
por: Arulkumaran, Nishkantha, et al.
Publicado: (2020) -
Bleeding outcomes in thrombocytopenic acute leukemic patients with venous thromboembolism
por: Wilson, Nathaniel R., et al.
Publicado: (2020) -
Thrombotic microangiopathies: First report of 294 cases from a single institution experience in Argentina
por: Dos Santos, Célia, et al.
Publicado: (2021) -
Acute dilated cardiomyopathy in the setting of catastrophic antiphospholipid syndrome and thrombotic microangiopathy: A case series and review
por: Hermel, Melody, et al.
Publicado: (2020)